InsidersTradesSigma
Track the 쎌바이오텍 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 쎌바이오텍 has logged 1 public disclosures. Market capitalisation: €101.6bn. The latest transaction was reported on 10 March 2026 (Other). Among the most active insiders: 쎌바이오텍. All data is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Cell Biotech 是一家在健康和制药领域运营的公司，在 XKRX 市场上市。它专注于开发创新的生物技术。